This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Summative Usability Study of CEREBO® - a Non Invasive Intracranial Hemorrhage Detector

Sponsored by Bioscan Research Pvt. Ltd.

About this trial

Last updated 3 years ago

Study ID

BR/US/2022/001

Status

Not yet recruiting

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Trial Timing

Ended 3 years ago

What is this trial about?

Traumatic brain injury is one of the most common reasons for visits to the Emergency Department. More than 90% of patients who have suffered from head trauma present with a mild traumatic brain injury. Most of these patients do not present any symptom at the time of diagnosis thus delaying the detection. CEREBO®, a non-invasive, portable, rapid, point-of-care intracranial haemorrhage detector can avoid delayed detection by decreasing the time from injury to the initial CT scan. The study aims at assessing the summative usability of the device by determining its ease of use, ease of learning and satisfaction among the medical health professionals. The participants will be trained before the study and will be assessed periodically. Each participant will use the device on at least 10 subjects.

What are the participation requirements?

Yes

Inclusion Criteria

- Medical health professionals >18 years of age with a valid medical license to practice medicine belonging to one of the following categories and have given a written consent to participate in the study.

- MBBS

- Ayush

- Nurse

- Others Subjects

- Of all ages and gender, have understood the study and gave a written informed consent.

No

Exclusion Criteria

- Cognitively impaired subjects unable to understand the study procedure